Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Kintor Pharmaceutical Ltd ( (HK:9939) ) is now available.
Kintor Pharmaceutical Ltd announced the successful completion of a top-up placing and subscription of new shares under a general mandate. A total of 20,673,000 shares were placed to independent third parties at HK$2.08 per share, with the same number of subscription shares issued to the vendor. This transaction did not result in any new substantial shareholders, indicating a strategic move to strengthen the company’s capital structure without altering its control dynamics.
More about Kintor Pharmaceutical Ltd
Kintor Pharmaceutical Ltd is a pharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative therapies. The company is listed on the Hong Kong Stock Exchange under the stock code 9939.
Average Trading Volume: 6,488,609
Technical Sentiment Signal: Buy
Current Market Cap: HK$924.6M
See more data about 9939 stock on TipRanks’ Stock Analysis page.